Status:

COMPLETED

Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study

Lead Sponsor:

Tanta University

Conditions:

Small Fiber Neuropathy

Diabetic Neuropathies

Eligibility:

All Genders

18+ years

Brief Summary

The aim of work is to study the clinical, electrodiagnostic and neurosonographic characteristics of diabetic patients with small fiber neuropathy in the Egyptian population, and to evaluate both the d...

Detailed Description

This case-control observational study is aiming to evaluate patients with diabetic small fiber neuropathy in the Egyptian. Diabetic small fiber neuropathy was defined as both of the following: A. Ty...

Eligibility Criteria

Inclusion

  • Patients diagnosed with diabetes mellitus or impaired glucose intolerance by laboratory investigations including any of the following: HbA1C, fasting blood sugar and 2-hour post prandial blood sugar, and/or antidiabetic medication.
  • Patients presented with small fiber neuropathy (SFN), including all the following:
  • A. Typical clinical symptoms of SFN such as burning or sharp pain in toes and feet, and on clinical examination: loss of small fiber modalities (pinprick and temperature), hyperalgesia, allodynia, and/or autonomic signs.
  • B. Reduced intraepidermal nerve fiber density (IENFD) in distal leg skin punch biopsy.
  • Age older than 18 years old

Exclusion

  • Mental illness that made interviewing ineffective
  • Physical illness leading to language and/or cognitive barrier
  • Other conditions that could cause neuropathy (e.g., chemotherapy, alcohol intake, established vitamin B12 deficiency, established hereditary neuropathy "or first-degree family members", active malignancy, chronic advanced liver or kidney diseases thought to cause neuropathy and history of bariatric surgery).
  • Atrial Fibrillation

Key Trial Info

Start Date :

January 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 22 2024

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT05993871

Start Date

January 1 2023

End Date

January 22 2024

Last Update

April 10 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ahmed Sami Mahmoud Alkotami

Kafr ash Shaykh, Egypt, 33511